Scientists reveal rare antibodies that target 'dark side' of flu virus
Scientists have uncovered antibodies that target the "dark side" of the flu virus. Influenza viruses have a mushroom-shaped protein known as neuraminidase (NA) that is said to have a "dark side" because the structure beneath its mushroom cap has been largely unexplored by science. Antibodies that latch onto this dark side could help form the basis for antiviral drugs and vaccines that work against many flu viruses, researchers wrote in a paper published Friday (March 1) in the journal Immunity . Currently, flu vaccines are designed to target a different structure on the surface of flu viruses: hemagglutinin (HA). This lollipop-shaped protein lets the viruses latch onto the outside of human cells and then infiltrate them. But it mutates rapidly, which is why the flu shot must be updated every year to match the HAs of circulating flu strains. Related: Never-before-seen antibodies can target many flu viruses By comparison, the dark side of NA doesn't mutate...